|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4745 | |
| A61K 31/4985 | |||
| A61K 31/513 | |||
| A61K 31/5517 | |||
| A61K 31/555 | |||
| A61K 31/704 | |||
| A61K 31/7068 | |||
| A61K 31/724 | |||
| A61K 33/24 | |||
| A61P 35/00 |
| (11) | Number of the document | 2173348 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08771559.5 |
| Date of filing the European patent application | 2008-06-20 | |
| (97) | Date of publication of the European application | 2010-04-14 |
| (45) | Date of publication and mention of the grant of the patent | 2015-12-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/067614 |
| Date | 2008-06-20 |
| (87) | Number | WO 2009/006043 |
| Date | 2009-01-08 |
| (30) | Number | Date | Country code |
| 947512 P | 2007-07-02 | US |
| (72) |
ABURUB, Aktham, US
CHEDID, Marcio, US
ENGLER, Thomas, Albert, US
VASUDEVAN, Venkatraghavan, US
|
| (73) |
Eli Lilly & Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | POTENTIATION OF CANCER CHEMOTHERAPY |
| POTENTIATION OF CANCER CHEMOTHERAPY |